Cargando…

Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota

Atherosclerosis (AS), especially atherosclerotic cardiovascular diseases (ASCVDs), and metabolic diseases (such as diabetes, obesity, dyslipidemia, and nonalcoholic fatty liver disease) are major public health issues worldwide that seriously threaten human health. Exploring effective natural product...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Shengjie, Li, Dan, Yu, Zongliang, Li, Yujuan, Wu, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299362/ https://www.ncbi.nlm.nih.gov/pubmed/34305616 http://dx.doi.org/10.3389/fphar.2021.709629

Ejemplares similares

Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE−/− Mice
por: Wu, Min, et al.
Publicado: (2020)

Mitochondria as novel mediators linking gut microbiota to atherosclerosis that is ameliorated by herbal medicine: A review
por: Li, Yujuan, et al.
Publicado: (2023)

Modulation of Gut Microbiota and Metabolites by Berberine in Treating Mice With Disturbances in Glucose and Lipid Metabolism
por: Fang, Xinyi, et al.
Publicado: (2022)

Effects of Berberine on Atherosclerosis
por: Rui, Rui, et al.
Publicado: (2021)

Mechanism and Potential Target of Blood-Activating Chinese Botanical Drugs Combined With Anti-Platelet Drugs: Prevention and Treatment of Atherosclerotic Cardiovascular Diseases
por: Li, Dan, et al.
Publicado: (2022)

The Role of Gut Microbiota in Atherosclerosis and Hypertension
por: Ma, Junli, et al.
Publicado: (2018)

The Enhanced Pharmacological Effects of Modified Traditional Chinese Medicine in Attenuation of Atherosclerosis Is Driven by Modulation of Gut Microbiota
por: Ji, Wenyan, et al.
Publicado: (2020)

Berberine Alleviates Non-alcoholic Steatohepatitis Through Modulating Gut Microbiota Mediated Intestinal FXR Activation
por: Shu, Xiangbing, et al.
Publicado: (2021)

Berberine-Loaded Carboxylmethyl Chitosan Nanoparticles Ameliorate DSS-Induced Colitis and Remodel Gut Microbiota in Mice
por: Zhao, Luqing, et al.
Publicado: (2021)

Gut Microbiota-Regulated Pharmacokinetics of Berberine and Active Metabolites in Beagle Dogs After Oral Administration
por: Feng, Ru, et al.
Publicado: (2018)

Berberine Regulates Treg/Th17 Balance to Treat Ulcerative Colitis Through Modulating the Gut Microbiota in the Colon
por: Cui, Huantian, et al.
Publicado: (2018)

Targeting gut microbiota and immune crosstalk: potential mechanisms of natural products in the treatment of atherosclerosis
por: Jing, Jinpeng, et al.
Publicado: (2023)

Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota
por: Yang, Sa, et al.
Publicado: (2022)

Effects of Berberine and Its Derivatives on Cancer: A Systems Pharmacology Review
por: Zhang, Chaohe, et al.
Publicado: (2020)

Polypharmacology of Berberine Based on Multi-Target Binding Motifs
por: Chu, Ming, et al.
Publicado: (2018)

Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target
por: Yang, Shengjie, et al.
Publicado: (2019)

Ginsenoside Rc ameliorated atherosclerosis via regulating gut microbiota and fecal metabolites
por: Xie, Bin, et al.
Publicado: (2022)

Mechanisms of Berberine for the Treatment of Atherosclerosis Based on Network Pharmacology
por: Xie, Xuejiao, et al.
Publicado: (2020)

The Effective Role of Natural Product Berberine in Modulating Oxidative Stress and Inflammation Related Atherosclerosis: Novel Insights Into the Gut-Heart Axis Evidenced by Genetic Sequencing Analysis
por: Cao, Richard Y., et al.
Publicado: (2021)

Alisma orientalis Beverage Treats Atherosclerosis by Regulating Gut Microbiota in ApoE(-/-) Mice
por: Zhu, Boran, et al.
Publicado: (2020)

Bile acids-gut microbiota crosstalk contributes to the improvement of type 2 diabetes mellitus
por: Gao, Ruolin, et al.
Publicado: (2022)

An Insight Into the Molecular Mechanism of Berberine Towards Multiple Cancer Types Through Systems Pharmacology
por: Guo, Pengfei, et al.
Publicado: (2019)

Pharmacological effects of berberine on models of ulcerative colitis: A meta-analysis and systematic review of animal studies
por: Hu, Shuangyuan, et al.
Publicado: (2022)

Stachyose Improves the Effects of Berberine on Glucose Metabolism by Regulating Intestinal Microbiota and Short-Chain Fatty Acids in Spontaneous Type 2 Diabetic KKAy Mice
por: Cao, Hui, et al.
Publicado: (2020)

Roles and Mechanisms of Hawthorn and Its Extracts on Atherosclerosis: A Review
por: Wu, Min, et al.
Publicado: (2020)

Network pharmacological analysis of Xuefu Zhuyu decoction in the treatment of atherosclerosis
por: Yuan, Jinxia, et al.
Publicado: (2022)

Alterations and Potential Applications of Gut Microbiota in Biological Therapy for Inflammatory Bowel Diseases
por: Pu, Dan, et al.
Publicado: (2022)

Macrophage Death as a Pharmacological Target in Atherosclerosis
por: Martinet, Wim, et al.
Publicado: (2019)

Astragaloside IV improves the pharmacokinetics of febuxostat in rats with hyperuricemic nephropathy by regulating urea metabolism in gut microbiota
por: Zhao, Zhen Xiong, et al.
Publicado: (2022)

Crosstalk Between Polygonatum kingianum, the miRNA, and Gut Microbiota in the Regulation of Lipid Metabolism
por: Dong, Jincai, et al.
Publicado: (2021)

Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine
por: Zhang, Feifei, et al.
Publicado: (2019)

The interplay between herbal medicines and gut microbiota in metabolic diseases
por: Wang, Lijie, et al.
Publicado: (2023)

The role of the gut microbiota and probiotics associated with microbial metabolisms in cancer prevention and therapy
por: Wang, Zijun, et al.
Publicado: (2022)

Ferulic Acid Ameliorates Atherosclerotic Injury by Modulating Gut Microbiota and Lipid Metabolism
por: Gu, Yuyan, et al.
Publicado: (2021)

Berberine: A Review of its Pharmacokinetics Properties and Therapeutic Potentials in Diverse Vascular Diseases
por: Ai, Xiaopeng, et al.
Publicado: (2021)

Therapeutic Effects of Berberine on Liver Fibrosis are associated With Lipid Metabolism and Intestinal Flora
por: Liu, Xianzhi, et al.
Publicado: (2022)

Efficacy and underlying mechanisms of berberine against lipid metabolic diseases: a review
por: Cai, Yajie, et al.
Publicado: (2023)

The Role of Gut Microbiota on Cholesterol Metabolism in Atherosclerosis
por: Vourakis, Margaret, et al.
Publicado: (2021)

The regulatory effects of second-generation antipsychotics on lipid metabolism: Potential mechanisms mediated by the gut microbiota and therapeutic implications
por: Chen, Hui, et al.
Publicado: (2023)

Influence of the gut microbiota on endometriosis: Potential role of chenodeoxycholic acid and its derivatives
por: Li, Yangshuo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_19l8m1lplpm4ih5v1n1oofkvu8